ALEGLITAZAR
- Product Name
- ALEGLITAZAR
- CAS No.
- 475479-34-6
- Chemical Name
- ALEGLITAZAR
- Synonyms
- R1439;R 1439;R-1439;RO0728804;RO-0728804;RO 0728804;ALEGLITAZAR;Unii-41T4oag59u;Aleglitazar, 10 mM in DMSO;R1439;RO0728804;R-1439;RO-0728804;R 1439;RO 0728804
- CBNumber
- CB51011727
- Molecular Formula
- C24H23NO5S
- Formula Weight
- 437.51
- MOL File
- 475479-34-6.mol
ALEGLITAZAR Property
- Melting point:
- 146-147 °C
- Boiling point:
- 665.2±65.0 °C(Predicted)
- Density
- 1.290
- storage temp.
- Store at -20°C
- solubility
- DMSO: ≥ 50 mg/mL (114.28 mM); Water: < 0.1 mg/mL (insoluble)
- pka
- 3.54±0.46(Predicted)
- form
- Powder
- color
- White to yellow
Hazard and Precautionary Statements (GHS)
- Symbol(GHS)
-
- Signal word
- Warning
- Hazard statements
-
H302Harmful if swallowed
H312Harmful in contact with skin
H315Causes skin irritation
H319Causes serious eye irritation
- Precautionary statements
-
P261Avoid breathing dust/fume/gas/mist/vapours/spray.
P280Wear protective gloves/protective clothing/eye protection/face protection.
P301+P312IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P302+P352IF ON SKIN: wash with plenty of soap and water.
P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.
N-Bromosuccinimide Price
- Product number
- BRS0001095
- Product name
- ALEGLITAZAR
- Purity
- 95.00%
- Packaging
- 5MG
- Price
- $559.9
- Updated
- 2021/12/16
- Product number
- orb611764
- Product name
- Aleglitazar
- Packaging
- 10mg
- Price
- $598.4
- Updated
- 2021/12/16
- Product number
- CS-1134
- Product name
- Aleglitazar
- Purity
- 99.30%
- Packaging
- 5mg
- Price
- $650
- Updated
- 2021/12/16
- Product number
- CS-1134
- Product name
- Aleglitazar
- Purity
- 99.30%
- Packaging
- 10mg
- Price
- $950
- Updated
- 2021/12/16
- Product number
- orb611764
- Product name
- Aleglitazar
- Packaging
- 50mg
- Price
- $1203.6
- Updated
- 2021/12/16
ALEGLITAZAR Chemical Properties,Usage,Production
Uses
Aleglitazar (R1439) is a potent dual PPARα/γ agonist, with IC50s of 38 nM and 19 nM for human PPARa and PPARγ, respectively. Aleglitazar can be used for the research of type II diabetes[1].
in vivo
Aleglitazar (0.3-3.0 mg/kg; i.p.; daily; for 7 days) exerts beneficial effects on structural and functional outcomes of mild brain ischemia[3].
Aleglitazar reduces key aspects of microglia activation including NO production, release of proinflammatory cytokines, migration, and phagocytosis[3].
Aleglitazar attenuates inflammatory responses in post-ischemic brain[3].
| Animal Model: | Male 129S6/SvEv mice (24-30 g), middle cerebral artery occlusion (MCAo) models[3] |
| Dosage: | 0.3 mg/kg, 3.0 mg/kg |
| Administration: | Intraperitoneal injection, daily, for 7 days |
| Result: | Reduced the size of the ischemic lesion as assessed using NeuN immunohistochemistry on day 7. |
target
PPAR
IC 50
PPARγ: 19 nM (IC50); PPARα: 38 nM (IC50)
References
[1] Bénardeau A, Benz J, Binggeli A, et al. Aleglitazar, a new, potent, and balanced dual PPARalpha/gamma agonist for the treatment of type II diabetes. Bioorg Med Chem Lett. 2009 May 1;19(9):2468-73. DOI:10.1016/j.bmcl.2009.03.036
[2] Yan Chen, et al. Aleglitazar, a dual peroxisome proliferator-activated receptor-α and -γ agonist, protects cardiomyocytes against the adverse effects of hyperglycaemia. Diab Vasc Dis Res. 2017 Mar; 14(2): 152–162. DOI:10.1177/1479164116679081
[3] Valérie Boujon, et al. Dual PPARα/γ agonist aleglitazar confers stroke protection in a model of mild focal brain ischemia in mice. J Mol Med (Berl). 2019; 97(8): 1127-1138. DOI:10.1007/s00109-019-01801-0
ALEGLITAZAR Preparation Products And Raw materials
Raw materials
Preparation Products
ALEGLITAZAR Suppliers
- Tel
- 1-(800)-881-8210
- Fax
- 615-250-9817
- inquiries@lgmpharma.com
- Country
- United States
- ProdList
- 2123
- Advantage
- 70
- Tel
- 0086-21-67651709
- Fax
- 0086-21-67651705
- cfx759@hotmail.com
- Country
- China
- ProdList
- 410
- Advantage
- 57
- Tel
- 1-631-485-4226; 16314854226
- info@bocsci.com
- Country
- United States
- ProdList
- 12952
- Advantage
- 65
- Tel
- 021-58955995
- Fax
- 609-228-5909
- sales@medchemexpress.cn
- Country
- United States
- ProdList
- 4861
- Advantage
- 58
- Tel
- sales@witofly.com
- Country
- China
- ProdList
- 2864
- Advantage
- 52
- Tel
- 0531-85828981
- Fax
- +86-531-85806006
- 864598798@qq.com
- Country
- China
- ProdList
- 588
- Advantage
- 58
- Tel
- +86-21-5821 5861
- Fax
- +86-21-5106 2861
- sales@letopharm.com
- Country
- China
- ProdList
- 2384
- Advantage
- 58
- Tel
- Fax
- -
- eric_feng1954@126.com
- Country
- China
- ProdList
- 9248
- Advantage
- 55
- Tel
- 18620099427
- Fax
- +86-20-62619665
- amy@howeipharm.com
- Country
- China
- ProdList
- 6687
- Advantage
- 55
- Tel
- +86-400-851-9921
- Fax
- +86-10-82826195
- sales@pharmacodia.com
- Country
- China
- ProdList
- 2317
- Advantage
- 55